| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.035 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |